On January 7, 2021 Apexigen, Inc., a clinical-stage biopharmaceutical company, reported that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will participate in two upcoming virtual investor healthcare conferences (Press release, Apexigen, JAN 7, 2021, View Source [SID1234573662]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Solebury Trout Virtual Management Access Event being held January 6 – 15, 2021. The Company will be conducting one-on-one meetings.
H.C. Wainwright Virtual BioConnect 2021 Conference. The Company’s presentation will be available on-demand from January 11 – 14, 2021.